Notas de prensa

  • 16 de diciembre de 2010
  • 176

the IDIBELL Cancer Conference (ICC) on Metastasis and Angiogenesis

Dear Friends and Colleagues:

 

It is my pleasure to invite you to attend the IDIBELL Cancer Conference (ICC) on Metastasis and Angiogenesis that will take place in Barcelona during May 26-27 2011.

 

The ICC on Metastasis and Angiogenesis is co-organized by Dr Manel Esteller (Cancer Epigenetics and Biology Program (PEBC), IDIBELL, Barcelona, Spain), Oriol Casanovas (Institut Català d’Oncologia (ICO), IDIBELL), Francesc Viñals Canals (Universitat de Barcelona, ICO, IDIBELL) and Danny R. Welch (University of Alabama, Birmingham AL, USA). The sessions will take place at the Hesperia Tower Hotel (L’Hospitalet de Llobregat, Barcelona, Spain), will last for 2 days (May 26-27, 2011) and will host a total of 20 plenary conferences given by the most recognized international experts in the field (see attached Poster) and poster/oral presentations that will be selected among conference applicants.

 

The main objective of the ICC on Metastasis and Angiogenesis is to highlight the latest advances in the biological mechanisms and the natural history of metastasis and angiogenesis in tumorigenesis and to provide an opportunity for the best scientific experts in these fields of research to meet and exchange scientific views and knowledge. At a more general level, we wish it to be a means of contact between the members of the scientific world as well as a chance for scientists who are starting their career to have access to the latest discoveries made in the Metastasis and Angiogenesis fields. This conference is thus open to the whole international scientific community, and more concretely to scientists who are developing their research in the field of Metastasis and Angiogenesis.

 

Please be so kind to find attached the Poster of the ICC on Metastasis and Angiogenesis.

 

For any further information please, visit our PEBC web page (www.pebc.cat ), and the ICC web page (http://iccmet2011.idibell.cat/) for Registration

 

Destacadas

  • El 45% de los pacientes con hipofosfatemia ligada al cromosoma X (XLH) padece hipertensión arterial, un porcentaje significativamente mayor al de la población general[1]

    Ariana del Río García

    El 45% de los pacientes con hipofosfatemia ligada al cromosoma X (XLH) padece hipertensión arterial, un porcentaje significativamente mayor al de la población general[1]

    Leer más
  • 7 de cada 10 pacientes hospitalizados presenta fragilidad y sarcopenia, lo que aumenta el riesgo de caídas[1]

    Ariana del Río García

    7 de cada 10 pacientes hospitalizados presenta fragilidad y sarcopenia, lo que aumenta el riesgo de caídas[1]

    Leer más
  • La inteligencia artificial y el big data revolucionan la investigación en nutrición clínica mediante nuevos diseños científicos

    Ariana del Río García

    La inteligencia artificial y el big data revolucionan la investigación en nutrición clínica mediante nuevos diseños científicos

    Leer más

Newsletter

Suscríbete para conocer las novedades del mundo farmacéutico y sanitario.

¿Qué es?

FarmaNews pone a disposición de los medios y departamentos de comunicación, un canal para publicar notas de prensa y convocatorias del mundo sanitario y farmacéutico.

Contacto

Avda. Mare de Déu de Lourdes, 108,
08757, Corbera de Llobregat
(Barcelona), España